Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy

DeVos, Sarah L., Miller, Rebecca L., Schoch, Kathleen M., Holmes, Brandon B., Kebodeaux, Carey S., Wegener, Amy J., Chen, Guo, Shen, Tao, Tran, Hien, Nichols, Brandon, Zanardi, Tom A., Kordasiewicz, Holly B., Swayze, Eric E., Bennett, C. Frank, Diamond, Marc I., Miller, Timothy M.·2017·Science Translational Medicine

DOI 10.1126/scitranslmed.aag0481

Cited by (518)

Items 101–200 of 518

Exploring the Regulatory Role of Circular RNAs in Neurodegenerative Disorders
Eleonora D’Ambra, Davide Capauto, Mariangela Morlando · 2019 · International Journal of Molecular Sciences
Aggregate-selective removal of pathological tau by clustering-activated degraders
Jonathan Benn, Shi Cheng, Sophie Keeling, Annabel E. Smith, Marina J. Vaysburd, Dorothea Böken, Lauren V. C. Miller, Taxiarchis Katsinelos, Catarina Franco, Elian Dupré et al. · 2024 · Science
Suppression of proteolipid protein rescues Pelizaeus–Merzbacher disease
Matthew S. Elitt, Lilianne Barbar, H. Elizabeth Shick, Berit E. Powers, Yuka Maeno-Hikichi, Mayur Madhavan, Kevin Cameron Allan, Baraa S. Nawash, Artur S. Gevorgyan, Stevephen Hung et al. · 2020 · Nature
Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay
Andrew D. Nguyen, Thi A. Nguyen, Jiasheng Zhang, Swathi Devireddy, Ping Zhou, Anna M. Karydas, Xialian Xu, Bruce L. Miller, Frank Rigo, Shawn M. Ferguson et al. · 2018 · Proceedings of the National Academy of Sciences
A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies
Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling, Claudia Balducci · 2021 · Alzheimer s & Dementia
Antisense oligonucleotide therapy for KCNT1 encephalopathy
Burbano, Lisseth Estefania, Li, Melody, Jancovski, Nikola, Jafar-Nejad, Paymaan, Richards, Kay, Sedo, Alicia, Soriano, Armand, Rollo, Ben, Jia, Linghan, Gazina, Elena V. et al. · 2022 · JCI Insight
Ordered Assembly of Tau Protein and Neurodegeneration
Michel Goedert, Maria Grazia Spillantini · 2019 · Advances in experimental medicine and biology
P-tau217 correlates with neurodegeneration in Alzheimer’s disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy
Denghong Zhang, Wei Zhang, Ming Chen, Xuheng Gao, Huilong Yuan, Xiaojie Lin, Xinru Mao, Chunping Wang, Xiaoyi Guo, Ying Du et al. · 2024 · Neuron
Oligonucleotide therapeutics in neurodegenerative diseases
Daniel R. Scoles, Stefan M. Pulst · 2018 · RNA Biology
Cellular and regional vulnerability in frontotemporal tauopathies
Shelley L. Forrest, Jillian J. Kril, Glenda Margaret Halliday · 2019 · Acta Neuropathologica
New directions in clinical trials for frontotemporal lobar degeneration: methods and outcome measures
Boxer, Adam L., Gold, Michael, Feldman, Howard, Boeve, Bradley F., Dickinson, Susan L.-J., Fillit, Howard, Ho, Carole, Paul, Robert, Pearlman, Rodney, Sutherland, Margaret et al. · 2020 · Alzheimer's & Dementia
Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy
Si Jie Tang, Arman Fesharaki‐Zadeh, Hideyuki Takahashi, Sarah Helena Nies, Levi M. Smith, Anin Luo, Annabel S. Chyung, Marius Chiasseu, Stephen M. Strittmatter · 2020 · Acta Neuropathologica Communications
Prion-like mechanisms in Alzheimer disease
Lary C. Walker · 2018 · Handbook of clinical neurology
Impairments of glutamatergic synaptic transmission in Alzheimer’s disease
Benedikt Zott, Arthur Konnerth · 2022 · Seminars in Cell and Developmental Biology
Microglia: Friend and foe in tauopathy
Odfalk, Kristian F., Bieniek, Kevin F., Hopp, Sarah C. · 2022 · Progress in Neurobiology
FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
Senthilvelrajan Kaniyappan, Katharina Tepper, Jacek Biernat, RamReddy Chandupatla, Sabrina Hübschmann, Stephan H. Irsen, Sandra Bicher, Christoph Klatt, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2020 · Molecular Neurodegeneration
Tau-targeting therapy in Alzheimer’s disease: Critical advances and future opportunities
Guo, Yi, Li, Song, Zeng, Ling-Hui, Tan, Jun · 2022 · Ageing and Neurodegenerative Diseases
Codonopsis pilosula Polysaccharide Attenuates Tau Hyperphosphorylation and Cognitive Impairments in hTau Infected Mice
Qing Zhang, Yiyuan Xia, Hongbin Luo, Sheng Huang, Yongjun Wang, Yangping Shentu, Yacoubou Abdoul Razak Mahaman, Fang Huang, Dan Ke, Qun Wang et al. · 2018 · Frontiers in Molecular Neuroscience
Targeting Alzheimer's disease with gene and cell therapies
Raúl Loera‐Valencia, Antonio Piras, Muhammad-Al-Mustafa Ismail, Shaffi Manchanda, Helga Eyjolfsdottir, Takaomi C. Saido, Jan Johansson, Maria Eriksdotter, Bengt G. Winblad, Per Nilsson · 2018 · Journal of Internal Medicine
A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice
Tomohiro Onishi, Ryouta Maeda, Michiko Terada, Sho Sato, Takahiro Fujii, Masahiro Ito, Kentaro Hashikami, Tomohiro Kawamoto, Maiko Tanaka · 2021 · Scientific Reports
Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis
Wen Hui Hu, Feng Wu, Yanchong Zhang, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2017 · Frontiers in Aging Neuroscience
Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer’s Disease
Diana Furcila, Marta Domínguez-Álvaro, Javier DeFelipe, Lidia Alonso‐Nanclares · 2019 · Frontiers in Neuroanatomy
TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model
Shao, Eric, Chang, Che-Wei, Li, Zhiyong, Yu, Xinxing, Ho, Kaitlyn, Zhang, Michelle, Wang, Xin, Simms, Jeffrey, Lo, Iris, Speckart, Jessica et al. · 2022 · Science Translational Medicine
Protein misfolding and related human diseases: A comprehensive review of toxicity, proteins involved, and current therapeutic strategies
Asra Nasir Khan, Rizwan Hasan Khan · 2022 · International Journal of Biological Macromolecules
A single-cell map of antisense oligonucleotide activity in the brain
Mortberg, Meredith A, Gentile, Juliana E, Nadaf, Naeem M, Vanderburg, Charles, Simmons, Sean, Dubinsky, Dan, Slamin, Adam, Maldonado, Salome, Petersen, Caroline L, Jones, Nichole et al. · 2023 · Nucleic Acids Research
Gene suppression approaches to neurodegeneration
Rhia Ghosh, Sarah J. Tabrizi · 2017 · Alzheimer s Research & Therapy
A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
Friedel Drepper, Jacek Biernat, Senthilvelrajan Kaniyappan, Helmut E. Meyer, Eva‐Maria Mandelkow, Bettina Warscheid, Eckhard Mandelkow� · 2020 · Journal of Biological Chemistry
Alzheimer’s disease and related tauopathies: disorders of disrupted neuronal identity
Bess E Frost · 2023 · Trends in Neurosciences
Amyloid-β and Tau in Alzheimer’s Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies
Rebecca M. Nisbet, Jürgen Götz · 2018 · Journal of Alzheimer s Disease
Advances in treatment of frontotemporal dementia
Magrath Guimet, Nahuel, Zapata-Restrepo, Lina M., Miller, Bruce L. · 2022 · The Journal of Neuropsychiatry and Clinical Neurosciences
Discovery and Optimization of Tau Targeted Protein Degraders Enabled by Patient Induced Pluripotent Stem Cells-Derived Neuronal Models of Tauopathy
M. Catarina Silva, Ghata Nandi, Katherine A. Donovan, Quan Cai, Bethany C. Berry, Radosław P. Nowak, Eric S. Fischer, Nathanael S. Gray, Fleur M. Ferguson, Stephen J. Haggarty · 2022 · Frontiers in Cellular Neuroscience
Blood tau‐PT217 contributes to the anesthesia/surgery‐induced delirium‐like behavior in aged mice
Jing Lu, Feng Liang, Ping Bai, Chenghao Liu, Miao Xu, Zhengwang Sun, Wenjie Tian, Yuanlin Dong, Yiying Zhang, Qimin Quan et al. · 2023 · Alzheimer s & Dementia
Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model
Samantha M. Rossano, Aubrey S. Johnson, Anna P. Smith, Galen Ziaggi, Andrew E. Roetman, Diana Guzman, Amarachukwu Okafor, Julia Klein, Zeljko Tomljanovic, Yaakov Stern et al. · 2024 · Alzheimer s & Dementia
Four-Repeat Tauopathies: Current Management and Future Treatments
Lawren A. VandeVrede, Peter Alexander Ljubenkov, Julio C. Rojas, Ariane E. Welch, Adam L. Boxer · 2020 · Neurotherapeutics
Evolutionarily conserved regulators of tau identify targets for new therapies
Kim, Jiyoen, de Haro, Maria, Al-Ramahi, Ismael, Garaicoechea, Lorena Laura, Jeong, Hyun-Hwan, Sonn, Jun Young, Tadros, Bakhos, Liu, Zhandong, Botas, Juan, Zoghbi, Huda Yahya · 2023 · Neuron
Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders
Preetpal Kaur, Alisha Khera, Hema Kumari Alajangi, Akanksha Sharma, Pradeep K. Jaiswal, Gurpal Singh, Ravi Pratap Barnwal · 2022 · Molecular Neurobiology
Microglial Senescence and Activation in Healthy Aging and Alzheimer’s Disease: Systematic Review and Neuropathological Scoring
Antonio Malvaso, Alberto Gatti, Giulia Negro, Chiara Calatozzolo, Valentina Medici, Tino Emanuele Poloni · 2023 · Cells
The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system
Jenna M. Sullivan, Curt Mazur, Daniel A. Wolf, Laura L. Horky, Nicolas V. Currier, Bethany Fitzsimmons, Jacob Y. Hesterman, Rachel Pauplis, Scott Haller, Berit E. Powers et al. · 2020 · Journal of Translational Medicine
The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
Yin, Xiaomin, Qiu, Yanyan, Zhao, Chenhao, Zhou, Zheng, Bao, Junze, Qian, Wei · 2021 · Medical Science Monitor
Astrocytic 4R tau expression drives astrocyte reactivity and dysfunction
Lubov A. Ezerskiy, Kathleen M. Schoch, Chihiro Sato, Mariana Beltcheva, Kanta Horie, Frank Rigo, Ryan Martynowicz, Celeste M M. Karch, Randall John Bateman, Timothy M. Miller · 2021 · JCI Insight
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases
Jacob Helm, Ludger J. Schöls, Stefan Hauser · 2022 · Pharmaceutics
CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood–Brain Barrier and Towards Specific Cellular Targeting
Anisha A. D’souza, Saeideh Nozohouri, Benjamin Saul Bleier, Mansoor M. Amiji · 2022 · Pharmaceutical Research
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
Testa, Gabriella, Staurenghi, Erica, Giannelli, Serena, Gargiulo, Simona, Guglielmotto, Michela, Tabaton, Massimo, Tamagno, Elena, Gamba, Paola, Leonarduzzi, Gabriella · 2018 · Redox Biology
Disentangling tau: One protein, many therapeutic approaches
Courtney Lane‐Donovan, Adam L. Boxer · 2024 · Neurotherapeutics
Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy
Koller, Emily J, Gonzalez De La Cruz, Elsa, Machula, Timothy, Ibanez, Kristen R, Lin, Wen-Lang, Williams, Tosha, Riffe, Cara J, Ryu, Daniel, Strang, Kevin H, Liu, Xuefei et al. · 2019 · Human Molecular Genetics
Novel Targets for Alzheimer's Disease: A View Beyond Amyloid
William J. Ray, Virginie Buggia-Prévot · 2020 · Annual Review of Medicine
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade
Silvia Cantara, Giorgia Simoncelli, Claudia Ricci · 2024 · International Journal of Molecular Sciences
Uses for humanised mouse models in precision medicine for neurodegenerative disease
R. Nair, Silvia Corrochano, Samanta Gasco, Charlotte Tibbit, David Thompson, Cheryl Maduro, Zeinab Ali, Pietro Fratta, Abraham Acevedo‐Arozena, Thomas J. Cunningham et al. · 2019 · Mammalian Genome
Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
Zhang, Lan, Xia, Yiyuan, Gui, Yuran · 2023 · Frontiers in Aging Neuroscience
Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
Mark K. Schultz, Renee C. Gentzel, Marija Usenovic, Cheryl A. Gretzula, C. Ware, Sophie Parmentier‐Batteur, Joel B. Schachter, Hatim A. Zariwala · 2018 · Neurobiology of Disease
Nanotechnology-enabled gene delivery for cancer and other genetic diseases
Tong Jiang, Karina Marie Gonzalez, Leyla Estrella Cordova, Jianqin Lu · 2023 · Expert Opinion on Drug Delivery
Quantifying and mitigating motor phenotypes induced by antisense oligonucleotides in the central nervous system
Michael P. Moazami, Julia M Rembetsy-Brown, Samantha L. Sarli, Holly R McEachern, Feng Wang, Masahiro Ohara, Atish A. Wagh, Karen L. Kelly, Pranathi Meda Krishnamurthy, Alexandra Weiss et al. · 2024 · Molecular Therapy
Neuronal levels and sequence of tau modulate the power of brain rhythms
Melanie M. Das, Sumihiro Maeda, Bozhong Hu, Gui-Qiu Yu, Weikun Guo, Isabel Lopez, Xinxing Yu, Chao Tai, Xin Wang, Lennart Mucke · 2018 · Neurobiology of Disease
Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies
Narendran Annadurai, Juan Bautista De Sanctis, Marián Hajdúch, Viswanath Das · 2021 · Experimental Neurology
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, Zhang Li · 2023 · International Journal of Molecular Sciences
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Zeba Firdaus, Xiaogang Li · 2024 · International Journal of Molecular Sciences
Cytosolic condensates rich in polyserine define subcellular sites of tau aggregation
Evan Lester, Meaghan Van Alstyne, Kathleen L. McCann, Spoorthy Reddy, Li Yi Cheng, Jeff Kuo, James Pratt, Roy Parker · 2023 · Proceedings of the National Academy of Sciences
Disrupting pathologic phase transitions in neurodegeneration
Bryan T. Hurtle, Longxin Xie, Christopher J. Donnelly · 2023 · Journal of Clinical Investigation
Antisense therapies for movement disorders
Daniel R. Scoles, Stefan M. Pulst · 2019 · Movement Disorders
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Haiyun Chen, Yuhan Zeng, Dan Wang, Yichen Li, Jieyu Xing, Yuejia Zeng, Zheng Liu, Xinhua Zhou, Hui Jie Fan · 2024 · Molecules
Alzheimer’s disease patient-derived high-molecular-weight tau impairs bursting in hippocampal neurons
Sam Harris, Robert A. Ellingford, J. Hartmann, Debanjan Dasgupta, Marten Kehring, Rikesh M. Rajani, David R. Graykowski, Noé Quittot, Dhanush Sivasankaran, Caitlin Commins et al. · 2025 · Cell
The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders
Adam James Schwarz · 2021 · Neurotherapeutics
Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction
Lingyan Wang, J. Beth Kempton, Han Jiang, Francine M. Jodelka, Alev M. Brigande, Rachel A. Dumont, Frank Rigo, Jennifer J Lentz, Michelle L. Hastings, John V. Brigande · 2020 · Nucleic Acids Research
Neuronal deficiency of p38α‐MAPK ameliorates symptoms and pathology of APP or Tau‐transgenic Alzheimer’s mouse models
Laura Schnöder, Gilles Gasparoni, Karl J. V. Nordström, Andrea Schottek, Inge Tomic, Anne Christmann, Karl Herbert Schäfer, Michael Dieter Menger, Jörn Walter, Klaus C Fassbender et al. · 2020 · The FASEB Journal
New Approaches to the Treatment of Frontotemporal Dementia
Kyra D. Neylan, Bruce L. Miller · 2023 · Neurotherapeutics
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, You Jung, Diep, Yen N., Tran, Minh, Cho, Hansang · 2020 · International Journal of Molecular Sciences
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López · 2023 · Ageing Research Reviews
Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide
Mal‐Gi Choi, Mi Jin Kim, Do-Geun Kim, Ri Yu, You-Na Jang, Won‐Jong Oh · 2018 · PLoS ONE
Therapeutic strategies for targeting neurodegenerative protein misfolding disorders
Robert H. Scannevin · 2018 · Current Opinion in Chemical Biology
Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus
Thomas Paß, Rudolf J. Wiesner, David Pla‐Martín · 2021 · Frontiers in Molecular Biosciences
Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain
Youjin Lee, Morgan R. Miller, Marty A. Fernandez, Elizabeth L. Berg, Adriana M. Prada, Qing Ouyang, Michael Schmidt, Jill L. Silverman, Tracy L. Young‐Pearse, Eric M. Morrow · 2021 · Brain
Biodistribution and delivery of oligonucleotide therapeutics to the central nervous system: Advances, challenges, and future perspectives
Akihiko Goto, Syunsuke Yamamoto, Shinji Iwasaki · 2022 · Biopharmaceutics & Drug Disposition
Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
Carolyn Tallon, Benjamin J. Bell, Medhinee M. Malvankar, Pragney Deme, Carlos J. Nogueras‐Ortiz, Erden Eren, Ajit G. Thomas, Kristen R. Hollinger, Arindom Pal, Maja Mustapić et al. · 2023 · Translational Neurodegeneration
Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer’s Disease: Recent Advances and Perspectives
Naoyuki Suzuki, Takuya Hatta, Mana Ito, Ken‐ichi Kusakabe · 2024 · Chemical and Pharmaceutical Bulletin
Adeno‐associated virus‐based Alzheimer's disease mouse models and potential new therapeutic avenues
Lars Matthias Ittner, Matthias Klugmann, Yazi Diana Ke · 2019 · British Journal of Pharmacology
Tau Post-Translational Modifications: Potentiators of Selective Vulnerability in Sporadic Alzheimer’s Disease
Trae Carroll, Sanjib K Guha, Keith W. Nehrke, Gail V.W. Johnson · 2021 · Biology
Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
Feng Han, JiaQie Lee, Xi Chen, Jacob Ziontz, Tyler J. Ward, Susan M. Landau, Suzanne L. Baker, Theresa M. Harrison, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
Elisabetta Lauretti, Domenico Praticò · 2020 · Expert Opinion on Therapeutic Targets
Therapeutic antisense oligonucleotides for movement disorders
Epaminondas Doxakis · 2020 · Medicinal Research Reviews
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets
Omid Vakili, Pooria Asili, Zeinab Babaei, Maryam Mirahmad, Atoosa Keshavarzmotamed, Zatollah Asemi, Alireza Mafi · 2022 · CNS & Neurological Disorders - Drug Targets
Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase
Hideyuki Takahashi, Sanaea Z. Bhagwagar, Sarah Helena Nies, Hongping Ye, Xianlin Han, Marius Chiasseu, Guilin Wang, Ian R. Mackenzie, Stephen M. Strittmatter · 2024 · Nature Communications
Identification of an ERK Inhibitor as a Therapeutic Drug Against Tau Aggregation in a New Cell-Based Assay
Giacomo Siano, Maria Claudia Caiazza, Ivana Ollà, Martina Varisco, Giuseppe Madaro, Valentina Quercioli, Mariantonietta Calvello, Antonino Cattaneo, Cristina Di Primio · 2019 · Frontiers in Cellular Neuroscience
Discontinued disease-modifying therapies for Alzheimer’s disease: status and future perspectives
Bruno Pietro Imbimbo, Madia Lozupone, Mark Watling, Francesco Panza · 2020 · Expert Opinion on Investigational Drugs
Current Management and Emerging Therapies in Multiple System Atrophy
Matthew R. Burns, Nikolaus R. McFarland · 2020 · Neurotherapeutics
Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model
Wei Wang, Qing Cao, Tao Tan, Fengwei Yang, Jamal B. Williams, Zhen Yan · 2021 · Aging Cell
Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development
Bhavarth P. Dave, Yesha B. Shah, Kunal G. Maheshwari, Mohammad Kaif A. Mansuri, Bhadrawati Prajapati, Humzah I. Postwala, Mehul R. Chorawala · 2023 · Cellular and Molecular Neurobiology
Blocking the Thiol at Cysteine-322 Destabilizes Tau Protein and Prevents Its Oligomer Formation
Hui Chen, Simu Liu, Shuiming Li, Jierui Chen, Jiazuan Ni, Qiong Liu · 2018 · ACS Chemical Neuroscience
A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity
Travis Rush, Jonathan R. Roth, Samantha J. Thompson, Adam R. Aldaher, J. Nicholas Cochran, Erik D. Roberson · 2019 · Neurobiology of Disease
Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Shashikala Bhute, Deepaneeta Sarmah, Aishika Datta, Pallavi Rane, Amit Shard, Avirag Goswami, Anupom Borah, Kiran Kalia, Kunjan R. Dave, Pallab Bhattacharya · 2020 · ACS Pharmacology & Translational Science
Genome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons
Carlos G. Sanchez, Christopher M. Acker, Audrey J. Gray, Malini Varadarajan, Cheng Song, Nadire R. Cochran, Steven Paula, Alicia Lindeman, Shaojian An, Gregory McAllister et al. · 2021 · Communications Biology
Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease
Jonathan Benn, Aamir S. Mukadam, William A. McEwan · 2021 · Seminars in Cell and Developmental Biology
p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD
Gong, Ping, Chen, Yan-qing, Lin, Ai-hua, Zhang, Hai-bo, Zhang, Yan, Ye, Richard D., Yu, Yang · 2020 · Alzheimer's Research & Therapy
A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury
Xinyi Zhao, Wen Zeng, Hong Wei Xu, Zihan Sun, Yingxin Hu, Beibei Peng, Jennifer D. McBride, Jiangtao Duan, Juan Deng, Bin Zhang et al. · 2023 · Science Translational Medicine
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, Walaa A. El‐Dakroury, Sherif S. Abdel Mageed, Tohada M. AL‐Noshokaty, Mahmoud A. Elrebehy, Shereen Saeid Elshaer, Naira Ali Mahmoud, Doaa Fathi et al. · 2023 · Pathology - Research and Practice
Shared pathophysiology: Understanding stroke and Alzheimer’s disease
Sai Sriram, Yusuf Mehkri, Stephan S. Quintin, Brandon Peter Lucke-Wold · 2022 · Clinical Neurology and Neurosurgery
DNA nanoflower Oligo-PROTAC for targeted degradation of FUS to treat neurodegenerative diseases
Ruixin Ge, Miao Chen, Sijin Wu, Sirui Huang, Ping Zhou, Minghui Cao, Fan Zhang, Jinzhi Zang, Yigao Zhu, Jingrui Li et al. · 2025 · Nature Communications
Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis
Karen Ling, Michaela Jackson, Duah Alkam, Dawei Liu, Norm Allaire, Chao Sun, Mahmoud Kiaei, Alexander McCampbell, Frank Rigo · 2018 · Neurobiology of Disease
Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice
Tao Yang, Harry Liu, Kevin C Tran, Albert Leng, Stephen M. Massa, Frank M. Longo · 2020 · Acta Neuropathologica Communications
Antisense therapies in neurological diseases
J.-B. Brunet de Courssou, Alexandra Dürr, David Adams, Jean‐Christophe Corvol, Louise‐Laure Mariani · 2021 · Brain